{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T02:48:19Z","timestamp":1774666099135,"version":"3.50.1"},"reference-count":12,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Pulmonary mucormycosis (PM) is a rare and life-threatening fungal infection. Here, we report a case of an acute T lymphoblastic leukemia patient with mixed infections of lethal invasive Mucormycosis and multi-drug resistant (MDR) bacteria. After receiving anti-infection drugs to control the patient's fever, he was treated with induction chemotherapy. However, the malignant hematological disease was poorly controlled by the chemotherapy and the patient developed more symptoms of infection. Although the results of multiple \u03b2-D-Glucan (G) and Galactomannan (GM) tests remained negative, several pathogens were detected using metagenomic next-generation sequencing (mNGS). In particular, mNGS identified <jats:italic>Malassezia pachydermum, Mucor racemosus<\/jats:italic>, and <jats:italic>Lauteria mirabilis<\/jats:italic> in the peripheral blood and local secretion samples. The Mucor and bacterial infections were further confirmed via multi-site and repeated fungal and bacterial cultures, respectively. Despite adjusting the anti-infection therapy according to the diagnostic results, the patient's blood disease and symptoms of infection were not alleviated. Additionally, the MDR <jats:italic>Acinetobacter baumannii<\/jats:italic> infection\/colonization was not confirmed until the seventh culture of the peripheral venous catheter tip. Due to the patient's deteriorating conditions, his family decided to withdraw him from further treatment. Overall, mNGS can facilitate a diagnosis of Mucormycosis by providing clinical and therapeutic information to support conventional diagnostic approaches. For the early and timely diagnosis and treatment of PM, it is also necessary to consider the malignant hematological conditions and repeated tests through multiple detection methods.<\/jats:p>","DOI":"10.3389\/fmed.2022.854338","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T13:30:35Z","timestamp":1649683835000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Case Report: A Case of Acute T Lymphoblastic Leukemia With Mixed Infection of Lethal Invasive Mucormycosis and Multi-Drug Resistant Bacteria"],"prefix":"10.3389","volume":"9","author":[{"given":"Qingya","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiping","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0003-4975(94)90243-7","article-title":"Pulmonary mucormycosis: results of medical and surgical therapy","volume":"57","author":"Tedder","year":"1994","journal-title":"Ann Thorac Surg."},{"key":"B2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s15010-018-1149-x","article-title":"Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome","volume":"46","author":"Feng","year":"2018","journal-title":"Infection."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/diagnostics11071226","article-title":"Diagnosis of pneumonia due to invasive molds","volume":"11","author":"Foppiano Palacios","year":"2021","journal-title":"Diagnostics."},{"key":"B4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2214\/AJR.13.11463","article-title":"Imaging pulmonary infection: classic signs and patterns","volume":"202","author":"Walker","year":"2014","journal-title":"AJR Am J Roentgenol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1148\/rg.2020190156","article-title":"Pulmonary mucormycosis: risk factors, radiologic findings, and pathologic correlation","volume":"40","author":"Agrawal","year":"2020","journal-title":"Radiographics."},{"key":"B6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1378\/chest.68.1.65","article-title":"Pulmonary mucormycosis with massive fatal hemoptysis","volume":"68","author":"Murray","year":"1975","journal-title":"Chest"},{"key":"B7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: an update","volume":"6","author":"Skiada","year":"2020","journal-title":"J Fungi."},{"key":"B8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1086\/430710","article-title":"Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer","volume":"41","author":"Chamilos","year":"2005","journal-title":"Clin Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B\u2013based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2217\/fmb.14.23","article-title":"Laboratory diagnosis of mucormycosis: current status and future perspectives","volume":"9","author":"Lackner","year":"2014","journal-title":"Future Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.2147\/IDR.S333818","article-title":"Metagenomic next-generation sequencing for pulmonary fungal infection diagnosis: lung biopsy versus bronchoalveolar lavage fluid","volume":"14","author":"Yang","year":"2021","journal-title":"Infect Drug Resist."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.854338\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T13:30:39Z","timestamp":1649683839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.854338\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":12,"alternative-id":["10.3389\/fmed.2022.854338"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.854338","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"article-number":"854338"}}